Expression of angiopoietin-like protein 4 at the fracture site: Regulation by hypoxia and osteoblastic differentiation

Sabrina S. Wilson, Alice Wong, Chrisoula A. Toupadakis, Clare E Yellowley-genetos

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Vascular disruption that occurs as a consequence of bone fracture, leads to hypoxia at the site of damage. Hypoxia regulates the expression of a number of genes that can modulate energy conservation, cell survival, tissue regeneration and angiogenesis. In this study we investigated the expression of Angiopoietin-like 4, an adipocytokine that has additional roles in angiogenesis, at the fracture site. We demonstrate that Angptl4 mRNA expression increased early during fracture healing (day 3) returning close to baseline at day14. In the callus, Angptl4 mRNA was visualized in areas of condensing mesenchymal cells, callus cartilage and was especially high in mineralizing osteoblasts located in areas of new bone formation. In vitro, Angptl4 mRNA expression in osteoblasts increased under hypoxic conditions and in cells treated with the hypoxia mimetic desferrioxamine. Angptl4 levels were strongly induced at day 14 in differentiating MC3T3-E1 osteoblastic cells. Exogenous ANGPTL4 increased expression of Runx2, Spp1, vegfa, and Alp mRNA in differentiating osteoblasts. We suggest that the distribution of Angptl4 in the callus may be driven by hypoxia and that Angptl4 may play a role in osteoblastic differentiation, and possibly angiogenesis via regulation of VEGF. Further studies could reveal a dual role for Angptl4 in angiogenesis and osteogenesis.

Original languageEnglish (US)
Pages (from-to)1364-1373
Number of pages10
JournalJournal of Orthopaedic Research
Volume33
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Angiopoietins
Bony Callus
Osteoblasts
Messenger RNA
Osteogenesis
Proteins
Fracture Healing
Adipokines
Deferoxamine
Bone Fractures
Vascular Endothelial Growth Factor A
Cartilage
Blood Vessels
Regeneration
Cell Survival
Hypoxia
Genes

Keywords

  • angiopoietin-like 4
  • fracture
  • hypoxia
  • osteoblast
  • osteogenesis

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Expression of angiopoietin-like protein 4 at the fracture site : Regulation by hypoxia and osteoblastic differentiation. / Wilson, Sabrina S.; Wong, Alice; Toupadakis, Chrisoula A.; Yellowley-genetos, Clare E.

In: Journal of Orthopaedic Research, Vol. 33, No. 9, 01.09.2015, p. 1364-1373.

Research output: Contribution to journalArticle

@article{03c51819558941fc925b3d67e798a9eb,
title = "Expression of angiopoietin-like protein 4 at the fracture site: Regulation by hypoxia and osteoblastic differentiation",
abstract = "Vascular disruption that occurs as a consequence of bone fracture, leads to hypoxia at the site of damage. Hypoxia regulates the expression of a number of genes that can modulate energy conservation, cell survival, tissue regeneration and angiogenesis. In this study we investigated the expression of Angiopoietin-like 4, an adipocytokine that has additional roles in angiogenesis, at the fracture site. We demonstrate that Angptl4 mRNA expression increased early during fracture healing (day 3) returning close to baseline at day14. In the callus, Angptl4 mRNA was visualized in areas of condensing mesenchymal cells, callus cartilage and was especially high in mineralizing osteoblasts located in areas of new bone formation. In vitro, Angptl4 mRNA expression in osteoblasts increased under hypoxic conditions and in cells treated with the hypoxia mimetic desferrioxamine. Angptl4 levels were strongly induced at day 14 in differentiating MC3T3-E1 osteoblastic cells. Exogenous ANGPTL4 increased expression of Runx2, Spp1, vegfa, and Alp mRNA in differentiating osteoblasts. We suggest that the distribution of Angptl4 in the callus may be driven by hypoxia and that Angptl4 may play a role in osteoblastic differentiation, and possibly angiogenesis via regulation of VEGF. Further studies could reveal a dual role for Angptl4 in angiogenesis and osteogenesis.",
keywords = "angiopoietin-like 4, fracture, hypoxia, osteoblast, osteogenesis",
author = "Wilson, {Sabrina S.} and Alice Wong and Toupadakis, {Chrisoula A.} and Yellowley-genetos, {Clare E}",
year = "2015",
month = "9",
day = "1",
doi = "10.1002/jor.22898",
language = "English (US)",
volume = "33",
pages = "1364--1373",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Expression of angiopoietin-like protein 4 at the fracture site

T2 - Regulation by hypoxia and osteoblastic differentiation

AU - Wilson, Sabrina S.

AU - Wong, Alice

AU - Toupadakis, Chrisoula A.

AU - Yellowley-genetos, Clare E

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Vascular disruption that occurs as a consequence of bone fracture, leads to hypoxia at the site of damage. Hypoxia regulates the expression of a number of genes that can modulate energy conservation, cell survival, tissue regeneration and angiogenesis. In this study we investigated the expression of Angiopoietin-like 4, an adipocytokine that has additional roles in angiogenesis, at the fracture site. We demonstrate that Angptl4 mRNA expression increased early during fracture healing (day 3) returning close to baseline at day14. In the callus, Angptl4 mRNA was visualized in areas of condensing mesenchymal cells, callus cartilage and was especially high in mineralizing osteoblasts located in areas of new bone formation. In vitro, Angptl4 mRNA expression in osteoblasts increased under hypoxic conditions and in cells treated with the hypoxia mimetic desferrioxamine. Angptl4 levels were strongly induced at day 14 in differentiating MC3T3-E1 osteoblastic cells. Exogenous ANGPTL4 increased expression of Runx2, Spp1, vegfa, and Alp mRNA in differentiating osteoblasts. We suggest that the distribution of Angptl4 in the callus may be driven by hypoxia and that Angptl4 may play a role in osteoblastic differentiation, and possibly angiogenesis via regulation of VEGF. Further studies could reveal a dual role for Angptl4 in angiogenesis and osteogenesis.

AB - Vascular disruption that occurs as a consequence of bone fracture, leads to hypoxia at the site of damage. Hypoxia regulates the expression of a number of genes that can modulate energy conservation, cell survival, tissue regeneration and angiogenesis. In this study we investigated the expression of Angiopoietin-like 4, an adipocytokine that has additional roles in angiogenesis, at the fracture site. We demonstrate that Angptl4 mRNA expression increased early during fracture healing (day 3) returning close to baseline at day14. In the callus, Angptl4 mRNA was visualized in areas of condensing mesenchymal cells, callus cartilage and was especially high in mineralizing osteoblasts located in areas of new bone formation. In vitro, Angptl4 mRNA expression in osteoblasts increased under hypoxic conditions and in cells treated with the hypoxia mimetic desferrioxamine. Angptl4 levels were strongly induced at day 14 in differentiating MC3T3-E1 osteoblastic cells. Exogenous ANGPTL4 increased expression of Runx2, Spp1, vegfa, and Alp mRNA in differentiating osteoblasts. We suggest that the distribution of Angptl4 in the callus may be driven by hypoxia and that Angptl4 may play a role in osteoblastic differentiation, and possibly angiogenesis via regulation of VEGF. Further studies could reveal a dual role for Angptl4 in angiogenesis and osteogenesis.

KW - angiopoietin-like 4

KW - fracture

KW - hypoxia

KW - osteoblast

KW - osteogenesis

UR - http://www.scopus.com/inward/record.url?scp=84938844676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938844676&partnerID=8YFLogxK

U2 - 10.1002/jor.22898

DO - 10.1002/jor.22898

M3 - Article

C2 - 25864912

AN - SCOPUS:84938844676

VL - 33

SP - 1364

EP - 1373

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 9

ER -